TRANSACT TECHNOLOGIES INC (TACT)

US8929181035 - Common Stock

4.09  -0.03 (-0.73%)

Fundamental Rating

3

Taking everything into account, TACT scores 3 out of 10 in our fundamental rating. TACT was compared to 31 industry peers in the Technology Hardware, Storage & Peripherals industry. TACT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TACT does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

In the past year TACT has reported negative net income.
TACT had a positive operating cash flow in the past year.
In multiple years TACT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: TACT reported negative operating cash flow in multiple years.

1.2 Ratios

TACT has a Return On Assets (-3.90%) which is in line with its industry peers.
The Return On Equity of TACT (-5.13%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.9%
ROE -5.13%
ROIC N/A
ROA(3y)-3.54%
ROA(5y)-4.5%
ROE(3y)-5.29%
ROE(5y)-6.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TACT's Profit Margin has declined in the last couple of years.
TACT's Operating Margin has declined in the last couple of years.
TACT's Gross Margin of 50.27% is amongst the best of the industry. TACT outperforms 83.33% of its industry peers.
TACT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TACT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.27%
OM growth 3YN/A
OM growth 5Y-8.7%
PM growth 3YN/A
PM growth 5Y-8.05%
GM growth 3Y7.76%
GM growth 5Y1.54%

5

2. Health

2.1 Basic Checks

TACT does not have a ROIC to compare to the WACC, probably because it is not profitable.
TACT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TACT has more shares outstanding
The debt/assets ratio for TACT has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.71 indicates that TACT is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.71, TACT is doing good in the industry, outperforming 76.67% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that TACT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, TACT is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.71
ROIC/WACCN/A
WACC11.82%

2.3 Liquidity

TACT has a Current Ratio of 3.32. This indicates that TACT is financially healthy and has no problem in meeting its short term obligations.
TACT has a Current ratio of 3.32. This is amongst the best in the industry. TACT outperforms 86.67% of its industry peers.
TACT has a Quick Ratio of 1.83. This is a normal value and indicates that TACT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TACT (1.83) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.83

1

3. Growth

3.1 Past

TACT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -139.22%.
Measured over the past years, TACT shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.66% on average per year.
Looking at the last year, TACT shows a very negative growth in Revenue. The Revenue has decreased by -39.97% in the last year.
The Revenue has been growing slightly by 5.88% on average over the past years.
EPS 1Y (TTM)-139.22%
EPS 3YN/A
EPS 5Y-7.66%
EPS Q2Q%-166.67%
Revenue 1Y (TTM)-39.97%
Revenue growth 3Y33.39%
Revenue growth 5Y5.88%
Sales Q2Q%-36.78%

3.2 Future

TACT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -48.53% yearly.
TACT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.51% yearly.
EPS Next Y-164.02%
EPS Next 2Y-48.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-40.36%
Revenue Next 2Y-16.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TACT. In the last year negative earnings were reported.
Also next year TACT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

TACT's earnings are expected to decrease with -48.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.53%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for TACT!.
Industry RankSector Rank
Dividend Yield N/A

TRANSACT TECHNOLOGIES INC

NASDAQ:TACT (1/3/2025, 8:04:50 PM)

4.09

-0.03 (-0.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners61.84%
Inst Owner Change-0.19%
Ins Owners3.99%
Ins Owner Change1.13%
Market Cap40.94M
Analysts82.5
Price Target6.89 (68.46%)
Short Float %0.13%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.04%
Min EPS beat(2)26.47%
Max EPS beat(2)81.62%
EPS beat(4)4
Avg EPS beat(4)53.68%
Min EPS beat(4)26.47%
Max EPS beat(4)81.62%
EPS beat(8)8
Avg EPS beat(8)352.38%
EPS beat(12)11
Avg EPS beat(12)239.4%
EPS beat(16)13
Avg EPS beat(16)179.54%
Revenue beat(2)1
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-11.88%
Max Revenue beat(2)8.95%
Revenue beat(4)1
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-11.88%
Max Revenue beat(4)8.95%
Revenue beat(8)5
Avg Revenue beat(8)2.86%
Revenue beat(12)8
Avg Revenue beat(12)5.06%
Revenue beat(16)11
Avg Revenue beat(16)5.1%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-26.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.88
P/FCF N/A
P/OCF 104.98
P/B 1.07
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.04
OCFY0.95%
SpS4.64
BVpS3.83
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.9%
ROE -5.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.27%
FCFM N/A
ROA(3y)-3.54%
ROA(5y)-4.5%
ROE(3y)-5.29%
ROE(5y)-6.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.7%
PM growth 3YN/A
PM growth 5Y-8.05%
GM growth 3Y7.76%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.23%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 1.83
Altman-Z 3.71
F-Score4
WACC11.82%
ROIC/WACCN/A
Cap/Depr(3y)100.67%
Cap/Depr(5y)91.45%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-139.22%
EPS 3YN/A
EPS 5Y-7.66%
EPS Q2Q%-166.67%
EPS Next Y-164.02%
EPS Next 2Y-48.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.97%
Revenue growth 3Y33.39%
Revenue growth 5Y5.88%
Sales Q2Q%-36.78%
Revenue Next Year-40.36%
Revenue Next 2Y-16.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-146.17%
EBIT growth 3YN/A
EBIT growth 5Y-3.33%
EBIT Next Year-127.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.78%
FCF growth 3YN/A
FCF growth 5Y4.82%
OCF growth 1Y103.05%
OCF growth 3YN/A
OCF growth 5Y1.51%